Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Paolo Ricchi & Maria Marsella. (2015) Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes. Drug Design, Development and Therapy 9, pages 6475-6482.
Read now
Read now
Articles from other publishers (5)
George J. Kontoghiorghes. (2021) Differences between the European Union and United States of America in Drug Regulatory Affairs Affect Global Patient Safety Standards and Public Health Awareness: The Case of Deferasirox and Other Iron Chelating Drugs. Medicines 8:7, pages 36.
Crossref
Crossref
Upendra Bulbake, Alka Singh, Abraham J. Domb & Wahid Khan. (2019) Therapeutic Macromolecular Iron Chelators. Current Medicinal Chemistry 26:2, pages 323-334.
Crossref
Crossref
Christina N Kontoghiorghe & George J Kontoghiorghes. (2016) New developments and controversies in iron metabolism and iron chelation therapy. World Journal of Methodology 6:1, pages 1.
Crossref
Crossref
Jasmine L Hamilton & Jayachandran N Kizhakkedathu. (2015) Polymeric nanocarriers for the treatment of systemic iron overload. Molecular and Cellular Therapies 3:1.
Crossref
Crossref
Joshua P. Gray & Sidhartha D. Ray. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
259
272
.